Contemporary revascularization strategies in 2002.
This review analyzes important facets of contemporary percutaneous coronary interventions. The optimal strategy of acute myocardial infarction and shock is addressed, as is the role of angioplasty in multivessel coronary disease. Vascular Brachytherapy is essentially the sole available treatment modality for in-stent restenosis. The WRIST trials have provided the foundation for clinical experience and are discussed in detail. Finally, drug-eluting stents may become the next revolution in interventional cardiology and offer the hope of a "cure" for restenosis.
Ajani
Andrew E
AE
Division of Cardiology, Washington Hospital Center, Washington DC 20010, USA. ajaniandrew@hotmail.com
Waksman
Ron
R
D000800:Angioplasty, Balloon; D000818:Animals; D001918:Brachytherapy; D002317:Cardiovascular Agents / Q000008:administration & dosage / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000473:pathology / Q000601:surgery*; D006083:Graft Occlusion, Vascular / Q000517:prevention & control; D006801:Humans; D009203:Myocardial Infarction / Q000601:surgery; D009204:Myocardial Revascularization / Q000379:methods*; D012770:Shock, Cardiogenic / Q000601:surgery; D015607:Stents
D002317:Cardiovascular Agents